Advertisement

Topics

Netherlands Genomics Initiative NGI Company Profile

19:44 EDT 21st September 2018 | BioPortfolio

NGI has released its Strategic Plan 2008 - 2012. Central elements of the plan are continuation of the national approach to genomics, increased emphasis on social and economic returns, and further strengthening of the knowledge base (research, technology and education).

Location

P.O. Box 93035
The Hague
2509 AA
Netherlands

Contact

Phone: 31 70 344 0672, +31 70 344 0640
Fax: 31 70 344 0632
Email: info@genomics.nl


News Articles [784 Associated News Articles listed on BioPortfolio]

New initiative launched to support goals of Human Cell Atlas

Uri Laserson, PhD, Assistant Professor in the Department of Genetics and Genomics Sciences at the Icahn School of Medicine at Mount Sinai, and collaborators have been awarded one of 85 grants announce...

AstraZeneca Joins Horizon\'s Genomics Discovery Initiative

Horizon Discovery's Edit-R crRNA libraries adopted by AstraZeneca as part of its functional genomics discovery platform

Educational Videos Use Poetry, Dance, Animation and Storytelling to Teach Elements of Genomics

The September issue of The Genomics Landscape highlights five new educational videos that were unveiled as a part of the '15 for 15' celebration to commemorate the 15th annivarsary of the completion ...

New Educational Videos Use Poetry, Dance, Animation and Storytelling to Teach Elements of Genomics

The September issue of The Genomics Landscape highlights five new educational videos that were unveiled as a part of the '15 for 15' celebration to commemorate the 15th annivarsary of the completion ...

Genomics England announces appointment of global genomics pioneer as first CEO

Genomics England announces the appointment of its first Chief Executive Officer (CEO) today. Global genomics pioneer Professor John Mattick will join Genomics England in June. He will lead the organiz...

Rosetta Genomics Ltd.: Genoptix Completes Acquisition of PersonalizeDx from Rosetta Genomics

-First step in the process of Genoptix acquiring all of Rosetta Genomics -Next step is the completion of a merger for $8 million in cash pursuant to which value to Rosetta Genomics' equity holders...

UCSF Names First Chief Genomics Officer

David RathsRecognizing that genomics is playing an increasingly important role in medicine, the University of California San Francisco Health has appointed its first chief genomics officer (CGO).

Mount Sinai partners with Chan Zuckerberg Initiative to bring big data solution to biology

(The Mount Sinai Hospital / Mount Sinai School of Medicine) Uri Laserson, PhD, Assistant Professor in the Department of Genetics and Genomics Sciences at the Icahn School of Medicine at Mount Sinai, a...

Clinical Trials [519 Associated Clinical Trials listed on BioPortfolio]

Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response to IVF Drugs

The purpose of this study is to evaluate the effectiveness of a modified natural cycle in patients with previous poor response to infertility drugs, prior to proceeding to oocyte donation ...

Resuscitation Outcomes in the Netherlands

The Resuscitation Outcomes in the Netherlands - study assesses one-year survival and quality of life after In-Hospital Cardiac Arrest(IHCA). It's design is a multicenter prospective observ...

Southeast Netherlands Advanced Metastatic Breast Cancer Registry

The Southeast Netherlands Advanced Breast Cancer (SONABRE) Registry is a real life multi-center study. The registry aims to include all patients diagnosed with advanced breast cancer as of...

Ethical Dilemmas in Anaesthesiology in the Netherlands; a Qualitative Interview Study.

This study will describe which ethical dilemmas are experienced by anesthesiologist in the Dutch Healthcare system and what the current solving strategies are for these issues. Semi- struc...

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Companies [873 Associated Companies listed on BioPortfolio]

Netherlands Genomics Initiative NGI

NGI has released its Strategic Plan 2008 - 2012. Central elements of the plan are continuation of the national approach to genomics, increased emphasis on social and economic returns, and further stre...

InteRNA Genomics

InteRNA Genomics B.V., a subsidiary of InteRNA Technologies B.V. and based in Bilthoven, the Netherlands, offers services and software for processing, analyzing and presenting ultra-high-throughpu...

Dyadic Nederland BV

Dyadic Netherlands is a wholly owned subsidiary of Dyadic based in Wageningen, the Netherlands that is dedicated to research and development activities for the benefit of Dyadic, ...

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

More Information about "Netherlands Genomics Initiative NGI" on BioPortfolio

We have published hundreds of Netherlands Genomics Initiative NGI news stories on BioPortfolio along with dozens of Netherlands Genomics Initiative NGI Clinical Trials and PubMed Articles about Netherlands Genomics Initiative NGI for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Netherlands Genomics Initiative NGI Companies in our database. You can also find out about relevant Netherlands Genomics Initiative NGI Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record